Note 7 – Earnings (Loss) Per Share

 

Basic earnings (loss) per share is computed by dividing net income or loss attributable to common stockholders by the weighted-average number of shares of our Common Stock outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common S tock that shared in the earnings of the entity. Diluted earnings per share also utilize the treasury stock method which prescribes a theoretical buy-back of shares from the theoretical proceeds of all options and warrants outstanding during the period. Options and warrants outstanding to acquire shares of our Common Stock at September 30, 2015 and 2014 were 1,739,500 and 1,632,500, respectively.

 

For the nine months ended September 30, 2015 and 2014, and the three months ended September 30, 2014 dilutive earnings per share is the same as basic earnings per share due to (i) the inclusion of Common Stock, in the form of stock options and warrants (“Common Stock Equivalents”), would have an anti-dilutive effect on the loss per share or (ii) there were no Common Stock Equivalents for the respective period. For the nine months ended September 30, 2015 and 2014, there were 335,454 and 512,182 Common Stock Equivalents, respectively, which were in the money, that were excluded from the earnings per share computation as a consequence of their anti-dilutive effect. For the three months ended September 30, 2015 there were 375,253 Common Stock Equivalents, which were in the money, that were included in the earnings per share computation. For the three months ended September 30, 2014, there were 393,260 Common Stock Equivalents which were in the money, that were excluded from the earnings per share computation as a consequence of their anti-dilutive effect.

 

A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended     Three Months Ended     Nine Months Ended     Nine Months Ended  
    September 30, 2015     September 30, 2014     September 30, 2015     September 30, 2014  
    Income     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS  
Basic earnings (loss) per share   $ 602       16,597     $ 0.04     $ (3,216 )     18,208     $ (0.18 )   $ (2,344 )     16,171     $ (0.14 )   $ (7,158 )     17,216     $ (0.42 )
                                                                                                 
Dilutives:                                                                                                
Options     -       375       -       -       -       -       -       -       -       -       -       -  
                                                                                                 
Diluted income (loss) per share   $ 602       16,972     $ 0.04     $ (3,216 )     18,208     $ (0.18 )   $ (2,344 )     16,171     $ (0.14 )   $ (7,158 )     17,216     $ (0.42

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

Tender offer statement by Issuer - Nov. 20, 2017
Prophase Labs Reports Financial Results - Nov. 13, 2017
ProPhase Labs Just Filed Its Quarterly Report: Note 8 – Earnings (... - Nov. 13, 2017

Auto Refresh

Feedback